In a bold move, President Trump calls for pharmaceutical companies to justify the success of their Covid drugs amid a leadership crisis at the CDC. As the FDA tightens vaccine eligibility, tensions rise over vaccine efficacy and public health transparency.
This summer, the Hamptons is buzzing about the Velvet Rope smoothie from Drugstore. With its vibrant purple stripes, this $20 drink has become a status symbol for those in the know, especially among Dorsia members. Discover how social media and exclusivity are driving its popularity!
Surgeons have achieved a remarkable milestone by transplanting a genetically modified pig's lung into a brain-dead human, showcasing the potential of xenotransplantation amidst ongoing organ shortages. However, experts caution that much work remains before this can be considered a viable option for living patients.
A new retrospective study indicates that while GLP-1 receptor agonists for diabetes may slightly increase the risk of new-onset diabetic retinopathy, they also significantly reduce the risk of vision loss. Experts emphasize the importance of regular eye examinations for patients.
Recent studies suggest a link between GLP-1 medications like Ozempic and vision loss. Learn about the risks and what you need to know if you're using these popular diabetes drugs.
President Trump is directing the military to target drug cartels in Latin America, marking a significant shift in strategy against the flow of illicit drugs into the U.S. The move raises questions about potential military engagement and its implications.
New research suggests that acetaminophen, a common pain reliever, may increase risk-taking behavior by reducing negative emotions. With 25% of Americans using it weekly, the implications could be significant!
Are you one of the many Americans using GLP-1 drugs like Ozempic or Wegovy? Discover essential lifestyle tips to prevent nutrient deficiencies and muscle loss while maximizing your weight loss results!
Isomorphic Labs, leveraging AI breakthroughs from DeepMind, is on the brink of human clinical trials for cancer drugs. With major pharma partnerships, the future of drug design looks promising!
Hannah Mai, 37, battled Cushing's disease and lost 10 stones in two years through daily pilates and a high-protein diet, avoiding weight-loss drugs like Ozempic. Discover her inspiring journey!
